Renal function in hepatosplenic schistosomiasis - An assessment of renal tubular disorders

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Duarte, Daniella Bezerra ^a,b   Vanderlei, Lucas Alexandre ^a   De Azevêdo Bispo, Raianne Kívia ^a   Pinheiro, Maria Eliete ^a   Da Silva, Geraldo Bezerra ^c   Martins, Alice Maria Costa ^b   Meneses, Gdayllon Cavalcante ^b   De Francesco Daher, Elizabeth ^b  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSITY OF FORTALEZA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PRAZIQUANTEL; QUININE DERIVATIVE;

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOOD DEPRIVATION; HEPATOSPLENIC SCHISTOSOMIASIS; HUMAN; HUMAN TISSUE; KIDNEY CONCENTRATING CAPACITY; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; LIVER BIOPSY; MALE; MICROALBUMINURIA; PROTEIN FUNCTION; PROTEINURIA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SINGLE DRUG DOSE; SODIUM EXCRETION; URINE ACIDIFICATION; URINE OSMOLALITY; UROGENITAL SYSTEM PARAMETERS; WATER ABSORPTION; WATER DEPRIVATION; ALBUMINURIA; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY DISEASES; MIDDLE AGED; NEGLECTED DISEASES; OSMOLARITY; PATHOLOGY; PATHOPHYSIOLOGY; PH; SCHISTOSOMIASIS; SEVERITY OF ILLNESS INDEX; URINALYSIS; URINE;

SCHISTOSOMA MANSONI;

ADULT; ALBUMINURIA; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NEGLECTED DISEASES; OSMOLAR CONCENTRATION; PROTEINURIA; SCHISTOSOMIASIS; SEVERITY OF ILLNESS INDEX; URINALYSIS;

EID: 84919782538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115197     Document Type: Article

References (46)

1. Chitsulo L, Loverde P, Engels D (2004) Disease Watch: Schistosomiasis. TDR Nat Rev Microbiol 2: 12-13.
2. Barsoum R, Nabil M, Saady G, Genin C, Saleh E, et al. (1996) Immunoglobulin-A and the pathogenesis of schistosomal glomerulopathy. Kidney Int 50: 920-928.
3. Nussenzveig I, De-Brito T, Carneiro CR, Silva AM (2002) Human Schistosoma mansoni-associated glomerulopathy in Brazil. Nephrol Dial Transplant 17: 4-7.
4. Barsoum R (2004) The changing face of schistosomal glomerulopathy. Kidney Int 66: 2472-2484.
5. Martinelli R, Rocha H (1996) Review/Update in Clinical Nephrology: glomerular involvement in schistosomiasis. J Bras Nefrol 18: 279-282.
6. Sobh MA, Moustafa FE, Sally SM, Deelder AM, Ghoniem MA (1988) Characterization of kidney lesions in early schistosomal-specific nephropathy. Nephrol Dial Transplant 3: 392-398.
7. Abensur H, Nussenzveig I, Saldanha LB, Pestalozzi MS, Barros MT, et al. (1992) Nephrotic syndrome associated with hepatointestinal schistosomiasis. Rev Inst Med Trop Sao Paulo 34: 273-276.
8. Van-Velthuysen MLF (1996) Glomerulopathy associated with parasitic infections. Parasitol Today 12: 102-107.
9. Van-Marck EAE (1983) The glomerulopathy associated with Schistosoma mansoni infection. An experimental study in the mouse. Acta Leiden 50: 1-123.
10. Barsoum RS (1993) Schistosomal glomerulopathies. Kidney Int 44: 1-12.
11. Andrade ZA, Van Marck EAE (1984) Schistosomal glomerular disease. Mem Inst Oswaldo Cruz 79: 499-506.
12. Andrade ZA, Van Marck E (1987) Schistosomal glomerular disease. Mem Inst Osvaldo Cruz 82: 25-29.
13. Rodrigues VL, Otoni A, Voieta I, Antunes CM, Lambertucci JR (2010) Glomerulonephritis in schistosomiasis mansoni: a time to reappraise. Rev Soc Bras Med Trop 43: 638-642.
14. Dos-Santos WLC, Sweet GMM, Bahiense-Oliveira M, Rocha PN (2011) Schistosomal glomerulopathy and changes in the distribution of histological patterns of glomerular diseases in Bahia, Brazil. Mem Inst Oswaldo Cruz 106: 901-904.
15. Barsoum RS (1987) Schistosomal glomerulopathy: selection factors. Nephrol Dial Transplant 2: 488- 497.
16. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, et al. (1996) Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 7: 906-913.
17. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, et al. (2000) Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58: 684-690.
18. Dantas M, Romão EA, Costa RS, dos Reis MA, Vieira Neto OM, et al. (2007) Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies. Kidney Blood Press Res 30: 306-313.
19. Hanemann ALP, Libório AB, Daher EF, Martins AMC, Pinheiro MCC, et al. (2013) Monocyte Chemotactic Protein-1 (MCP-1) in Patients with Chronic Schistosomiasis Mansoni: Evidences of Subclinical Renal Inflammation. PLoS One 8: e80421.
20. Child CG, Turcotte JG (1964) Surgery and portal hypertension. In: Child CG, editor. The liver and portal hypertension. Philadelphia: Saunders. Pp. 50-64.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649.
22. Tryding N, Sterner G, Berg B, Harris A (1987) Subcutaneous and intranasal administration of 1- deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity. Nephron 45: 27- 30.
23. Oster JR, Hotchkiss JL, Carbon M, Farmer M, Vaamonde CA (1975) A short duration renal acidification test using calcium chloride. Nephron 14: 281-289.
24. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464-470.
25. Ginès P, Cardenas A, Arroyo V, Rodes J (2004) Management of Cirrhosis and Ascites. N Engl J Med 361: 1646-1654.
26. Ginès P, Schrier RW (2009) Renal failure in cirrhosis. N Engl J Med 361: 1279-1290.
27. Rebouças G (1975) Clinical Aspects of Hepatosplenic Schistosomiasis: A Contrast with Cirrhosis. Yale J Biol Med 48: 369-376.
28. De-Cock KM (1986) Hepatosplenic schistosomiasis: a clinical review. Gut 27: 734-745.
29. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, et al. (2002) Schistosomiasis. N Engl J Med 346: 1212-1220.
30. Martinelli R, Brito E, Rocha H (1980) Value of beta 1C/1A globulin serum levels as an early index of glomerular involvement in Schistosoma mansoni infection. Am J Trop Med Hyg 29: 882-995.
31. Martinelli R, Noblat ACB, Brito E, Rocha H (1989) Schistosoma mansoni-induced mesangiocapillary glomerulonephrites: Influence of therapy. Kidney Int 35: 1227-1233.
32. Oliveira RA, Lima CG, Mota RMS, Martins AM, Sanches TR, et al. (2012) Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial. BMC Nephrol 13: 44-49.
33. Chugh KS, Damle PB, Kaur S, Sharma BK, Kumar B, et al. (1983) Renal lesions in leprosy amongst north India patients. Postgrad Med J 59: 707-711.
34. Ponce P, Ramos A, Ferreira ML, Pinto G, Lacerda MH (1989) Renal involvement in leprosy. Nephrol Dial Transplant 4: 81-84.
35. Lima-Verde EM, Lima-Verde FAA, Lima-Verde FA, Silva-Juniore GB, Daher EF (2007) Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol 20: 432-438.
36. Drutz D, Gutman R (1971) Renal tubular acidosis in leprosy. Ann Intern Med 75: 475.
37. Sritharan V, Venkatesan K, Bharadwaj VP, Girdhar BK (1981) Renal functions in lepromatous leprosy patients. Lepr India 53: 437-442.
38. Sobh M, Moustafa F, El-Arbagy A, Shebab EL, Din M, et al. (1990) Nephropathy in asymptomatic patients with active Schistosoma mansoni infection. Int Urol Nephrol 22: 37-43.
39. Bina JC (1981) Influência da terapêutica específica na evolução da esquistossomose mansoni. Rev Patol Trop 10: 221-267.
40. Russo LM, Bakris GL, Comper WD (2002) Renal handling of lbumin: a critical review of basic concepts and perspective. Am J Kidney Dis 39: 899-919.
41. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al. (2001) Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and non-diabetic individuals. JAMA 286: 421- 426.
42. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, et al. (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. Ann Intern Med 139: 901-906.
43. Oliveira MJ, Silva Júniore GB, Abreu KL, Rocha NA, Garcia AV, et al. (2010) Risk factors for acute kidney injury in visceral leishmaniasis. Am J Trop Med Hyg 82: 449-453.
44. Elnojomi N, Musa AM, Younis BM, Elfaki M, El-Hassan AM, et al. (2010) Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. Saudi J Kidney Dis Transpl 21: 872-875.
45. Oliveira RA, Silva GB Jr, Souza CJ, Vieira EF, Mota RM, et al. (2008) Evaluation of renal function in leprosy: a study of 59 consecutive patients. Nephrol Dial Transplant 23: 256-262.
46. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Pereira AB (1993) Renal abnormalities in Leprosy. Nephron 65: 381-384.